To conclude, transgenic C. elegans models of human AD can be divided into two categories: the Aβ model (Table 1) and the tau model, which were specifically designed and constructed to mimic Aβ and/or tau pathological roles in AD development. The gene discussed is MAPT; the disease is Alzheimer disease.